Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Next Steps in Heart Failure: Changing Paradigms in Therapy to Unmet Needs
Author(s): Christiane Angermann , Javed Butler , Clyde W Yancy , et al Added: 1 year ago
During this broadcast, "Next Steps in Heart Failure: The Changing Paradigms in Therapy to the Unmet Needs", Radcliffe Medical Education brings together a globally-renowned European and American faculty to participate in a roundtable discussion. The aim: to provide both a reflection on the HF landscape following published data at congress and to examine what future developments can be expected at… View more

Heart Failure

Prevention & Chronic Conditions
What Matters to Patients: Metabolic Health Beyond Weight Loss
Author(s): Lee Kaplan , Fatima Cody Stanford , Filip Knop , et al Added: 9 months ago
Radcliffe Medical Education bring together a distinguished panel of globally renowned experts who provide guidance on navigating the ever-changing landscape of obesity and metabolic health management. Under the chairmanship of Prof Jason Halford(University of Leeds, UK), the panel includingDr Lee Kaplan(Obesity, Metabolism and Nutrition Institute, Massachusetts General Hospital, US),Dr… View more

Prevention & Chronic Conditions
ACC 23 Expert Consensus Decision Pathway on Cardiac Amyloidosis: Highlights
Author(s): Michelle Kittleson Added: 1 year ago
Dr Michelle Kittleson (Cedars-Sinai California Heart Center, US) provides an overview of the 2023 ACC Expert Consensus Decision Pathway on Comprehensive Multidisciplinary Care for the Patient with Cardiac Amyloidosis.Dr Kittleson highlights the unmet needs in managing patients with cardiac amyloidosis and stresses the importance of a multidisciplinary approach involving cardiologists,… View more

Standards & Guidelines

Heart Failure
EuroPCR 22: Transcatheter Tricuspid Valve Repair with PASCAL System
Author(s): Stephan Baldus Added: 1 year ago
Prof Stephan Baldus (University of Köln Medical Center, DE) shares insights from the TriCLASP post-market study (NCT04614402). This postmarket clinical follow up study, presented at EuroPCR 2022, assessed the safety and effectiveness of the Edwards PASCAL Transcatheter Valve Repair System in transcatheter tricuspid valve repair. Discussion Points: 1. Unmet needs of patients with TR 2. Study… View more

Intervention
TCT 23: 5Y Outcomes From the PARTNER 3 Low-Risk Trial
Author(s): Martin B Leon Added: 4 months ago
TCT 23 - In this short virtual interview, we are joined by Dr Martin B Leon (Columbia University Medical Center, US) to discuss the 5-year outcomes from Edwards' PARTNER 3 low-risk trial (NCT02675114).PARTNER 3 is a randomized, prospective, multicenter trial that aimed to determine the safety and effectiveness of the SAPIEN 3 transcatheter heart valve in patients with severe calcific aortic… View more

Intervention
EuroPCR 23: TRILUMINATE Pivotal: TEER for Tricuspid Regurgitation
Author(s): Paul Sorajja Added: 11 months ago
EuroPCR 23 - Dr Paul Sorajja (Abbott Northwestern Hospital, US) joined us to discuss the TRILUMINATE Pivotal study (NCT03904147). The aim of this trial is to evaluate the safety and effectiveness of the tricuspid transcatheter edge-to-edge repair (TriClip, Abbott) in improving clinical outcomes for symptomatic patients with severe tricuspid regurgitation (TR) who have an intermediate or higher… View more

Intervention
TCT 23: Four-Year Outcomes from the EVOLUT Low Risk Trial
Author(s): Michael J Reardon Added: 5 months ago
TCT 23 - In this succinct interview, we are joined by Dr Michael Reardon (Houston Methodist, US) to discuss the four-year outcomes from the EVOLUT Low-Risk Trial (NCT03635424), sponsored by Medtronic. The EVOLUT Low-risk trial is a multicenter, prospective, single-arm study which aimed to assess the procedural safety and efficacy of the Medtronic TAVR system in 150 patients with bicuspid… View more

Intervention
CRT 24: The CLIPPER Cohort
Author(s): Alexander Fanaroff Added: 4 weeks ago
CRT 24 - Dr Alexander Fanaroff (Penn Medicine, US) joins us in this short interview to discuss the findings of a national cohort of patients with chronic limb-threatening ischemia, CLIPPER.The CLIPPER cohort includes the baseline data and outcomes of 1.13 million patients with chronic limb-threatening ischemia.Findings from the study showed that for individuals with a diagnosis to limb… View more

Vascular Disease and Surgery
ESC 23: The ONCO DVT Study
Author(s): Yugo Yamashita Added: 7 months ago
ESC 23 — In this concise interview, Dr Yugo Yamashita (Kyoto University Graduate School of Medicine, JP) reveals the findings of the ONCO DVT Study (NCT03895502). The ONCO DVT study (Takeshi Morimoto) aimed to determine the ideal duration of anticoagulation therapy with the direct oral anticoagulant (DOAC) edoxaban for the treatment of isolated distal deep vein thrombosis (IDDVT) in patients… View more

Anticoagulation

Vascular Disease and Surgery
Obesity Management Strategies in 2023
Author(s): Harold Bays Added: 1 year ago
ACC.23/WCC — Dr Harold Bays, Science Officer for the Obesity Medicine Association, member of the Board of Trustees of the Obesity Medicine Association, and member of the Board of Directors of the American Society of Preventive Cardiology joins us to talk about obesity management and the emergence of anti-obesity drugs and multidisciplinary team approach. Discussion Points: Unmet Needs in the… View more

Prevention & Chronic Conditions